European Association for the Study of the Liver. (2018) EASL recommendations on treatment of Hepatitis C 2018. Journal of Hepatology, 69, (2), DOI: https://doi.org/10.1016/j.jhep.2018.03.026.
External website: https://www.journal-of-hepatology.eu/article/S0168...
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an enhanced understanding of the pathophysiology of the disease, and because of developments in diagnostic procedures and improvements in therapy and prevention. These European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.
B Substances > Alcohol
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
G Health and disease > Digestive system disease > Liver disease
G Health and disease > Digestive system disease > Liver disease > Liver cirrhosis
J Health care, prevention, harm reduction and treatment > Patient / client care management
J Health care, prevention, harm reduction and treatment > Health care delivery
J Health care, prevention, harm reduction and treatment > Health care administration > Health care quality control
N Communication, information and education > Recommendations
N Communication, information and education > Recommendations > Practice / clinical guidelines
VA Geographic area > Europe
Repository Staff Only: item control page